Article Information
History
- October 7, 2021.
Article Versions
- Version 1 (October 5, 2021 - 08:37).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Marie Suehiro, PhD1,
- Shinya Okubo, PhD2,
- Kensuke Nakajima, PhD2,
- Kosuke Kanda, PhD3,
- Masanobu Hayakawa, PhD3,
- Shigeru Oiso, PhD2,
- Tsutomu Kabashima, PhD4,
- Hideaki Fujita, PhD5,
- Yukio Ando, MD, PhD6 and
- Takahiro Muro, PhD1,*
- 1Division of Medical Informatics, Department of Pharmacy, Faculty of Pharmaceutical Sciences, Nagasaki International University, Japan
- 2Division of Pharmaceutical Health Care and Science, Department of Pharmacy, Faculty of Pharmaceutical Sciences, Nagasaki International University, Japan
- 3Division of Clinical Pharmaceutics, Department of Pharmacy, Faculty of Pharmaceutical Sciences, Nagasaki International University, Japan
- 4Division of Pharmaceutical Technology, Department of Pharmacy, Faculty of Pharmaceutical Sciences, Nagasaki International University, Japan
- 5Section of Functional Morphology, Department of Pharmacy, Faculty of Pharmaceutical Sciences, Nagasaki International University, Japan
- 6Division of Amyloidosis Research, Department of Pharmacy, Faculty of Pharmaceutical Sciences, Nagasaki International University, Japan
- ↵*Corresponding author; email: muroth1{at}niu.ac.jp
Posted October 07, 2021.
Adverse events following COVID-19 vaccination in young Japanese people: A case-control study of the risk of systemic adverse events by a questionnaire survey
